Bristol Myer Profile


Odds of Distress

Analyze Filter    Check how we calculate scores
Equity ratings for Bristol Myer Squi Pf are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 15, 2019 and ending today December 14, 2019. Click here to learn more.

Bristol Myer Profile

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, and distributes biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. Bristol Myers operates under Drug Manufacturers - Major classification in USA and is traded on OTC Market. It employs 23700 people. more
NameBristol Myer Squi Pf
CEO, DirectorLamberto AndreottiView All
Macroaxis Advice
InstrumentUSA OTC Stock View All
Business Address345 Park Avenue
ExchangeBATS Exchange
IndustryDrug Manufacturers - Major
Phone212 546 4000
CurrencyUSD - US Dollar
Bristol Myer Squi Pf [BMYMP] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mega-Cap' category with current market capitalization of 1640 B. Bristol Myer Squi classifies itself under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 1.64 B outstanding shares of which 10 shares are currently shorted by private and institutional investors with about 0.59 days to cover all short positions. BRISTOL MYER SQUI has accumulated about 6.07 B in cash with 5.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72.
Check Bristol Myer Probability Of Bankruptcy

Bristol Myer Target Price Odds Analysis

Odds Below 1054.3HorizonTargetOdds Above 1054.3
83.03%30 days 1,054 16.89%
Based on normal probability distribution, the odds of Bristol Myer to move above current price in 30 days from now is about 16.89 (This Bristol Myer Squi Pf probability density function shows the probability of Bristol Myer OTC Stock to fall within a particular range of prices over 30 days) .

Bristol Myer Squi Risk Profiles

Bristol Myer Key Fundamentals

Bristol Myer Against Markets

Did you try this?

Run Portfolio Anywhere Now


Portfolio Anywhere

Track or share privately all of your investments from the convenience of any device
All  Next Launch Module

Bristol Myer Distributions to stockholders

Bristol Myer Corporate Directors

Togo West Independent Director
Karen Vousden Director
Alan Lacy Independent Director
Check also Trending Equities. Please also try Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.